Miscarriage Clinical Trial
— MisTherOfficial title:
Interest of a Short Early Psychological Care in Women With Miscarriage: a Controlled Randomized Study
Miscarriage is a very common complication of pregnancy, accounting for 15.3% (95% CI 12.5-18.7%) of diagnosed pregnancies. Miscarriage would affect one in ten women during her lifetime. Worldwide, 23 million miscarriages occur annually. Because of its frequency, miscarriage isoften considered as trivial event by caregivers. Still, miscarriage can be a traumatic event. Literature is consistent on the psychological morbidity associated with miscarriage. Anxiety, depression, post-traumatic stress have been studied in women after miscarriage. Cohort studies and clinical trials suggest that psychological and supportive interventions performed in women after miscarriage may improve women's psychological well-being and reduce miscarriage complications in subsequent pregnancies. However, to date, the literature is considered insufficient on the psychological care of women after a miscarriage.
Status | Not yet recruiting |
Enrollment | 932 |
Est. completion date | December 1, 2026 |
Est. primary completion date | August 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - women with an early miscarriage (defined by a spontaneous termination of pregnancy before the 14th week of amenorrhea) - women aged more than 18 - women agreeing to participate in the study (signing the informed consent form). Exclusion Criteria: - ectopic pregnancy - molar pregnancy - women with recurrent miscarriages - women less than 18 |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Université de Reims Champagne-Ardenne |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | anxiety | Anxiety will be evaluated using the Scale Trait Anxiety Inventory version Y (STAI-Y-A). The STAI Form Y-A consists of a set of twenty item sonly focus on the psychological and not the somatic aspects of anxiety. The STAI Form Y-A is a self-reported questionnaire. Each item is scored from 1 to 4 and a sum score of all items is computed. Higher score indicates greater anxiety. Presence of anxiety will be defined by a score greater than or equal to 46. | Month 3 | |
Secondary | depression | depression will be evaluated using Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a self-reported index of depressive symptoms experienced in the past 2 weeks. The questionnaire includes 21 items of depression symptoms and attitude that the subjects must answer on a 4-point scale from 0 to 3 (0 = not at all bothered; 3 = severely bothered). The minimum score in this questionnaire is 0 and the maximum is 63. Total score indicates that depression is minimal (from 0 to 11 points), mild (from 12 to 19 points), moderate (from 20 to 35 points), or severe (from 36 to 63 points). Presence of depression will be defined by a score greater than or equal to 19. | month 3 | |
Secondary | anxiety | Anxiety will be evaluated using the Scale Trait Anxiety Inventory version Y (STAI-Y-A). The STAI Form Y-A consists of a set of twenty item sonly focus on the psychological and not the somatic aspects of anxiety. The STAI Form Y-A is a self-reported questionnaire. Each item is scored from 1 to 4 and a sum score of all items is computed. Higher score indicates greater anxiety. Presence of anxiety will be defined by a score greater than or equal to 46. | month 6 | |
Secondary | depression | depression will be evaluated using Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a self-reported index of depressive symptoms experienced in the past 2 weeks. The questionnaire includes 21 items of depression symptoms and attitude that the subjects must answer on a 4-point scale from 0 to 3 (0 = not at all bothered; 3 = severely bothered). The minimum score in this questionnaire is 0 and the maximum is 63. Total score indicates that depression is minimal (from 0 to 11 points), mild (from 12 to 19 points), moderate (from 20 to 35 points), or severe (from 36 to 63 points). Presence of depression will be defined by a score greater than or equal to 19. | month 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Enrolling by invitation |
NCT01689428 -
Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases
|
Phase 3 | |
Completed |
NCT00194844 -
Couples Miscarriage Healing Project:Randomized Trial
|
Phase 1/Phase 2 | |
Recruiting |
NCT05789940 -
Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention
|
N/A | |
Recruiting |
NCT03628625 -
Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage
|
Phase 2 | |
Not yet recruiting |
NCT05557201 -
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
|
||
Not yet recruiting |
NCT05579756 -
Psychatric Impact of Miscarriage in Assiut University Hospital
|
||
Not yet recruiting |
NCT05039853 -
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
|
N/A | |
Recruiting |
NCT01223482 -
A Study Looking at Women's Experiences After a Miscarriage
|
N/A | |
Completed |
NCT04604366 -
Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage
|
Phase 2 | |
Not yet recruiting |
NCT05088720 -
Misoprostol for Management of Women With an Incomplete Miscarriage
|
N/A | |
Not yet recruiting |
NCT05094375 -
Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage
|
N/A | |
Not yet recruiting |
NCT05088707 -
Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage
|
N/A | |
Not yet recruiting |
NCT05103098 -
Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage
|
N/A | |
Recruiting |
NCT05304273 -
Comparison Between Letrozole and Mifepristone in Medical Termination of First Trimester Miscarriages
|
Phase 3 | |
Recruiting |
NCT03976544 -
Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients
|
Phase 4 | |
Completed |
NCT01916928 -
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
|
N/A | |
Completed |
NCT03940495 -
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
|
||
Completed |
NCT04512820 -
Treatment of Missed Miscarriage With TRUCLEAR Tissue Removal System, a Feasiblity Study
|
N/A | |
Recruiting |
NCT05762770 -
A Trial of Sperm Injection (PICSI) on Miscarriage Rates in Assisted Conception
|
N/A |